In addition, several statins, used in the therapy of hypercholesterinemia, hypertension, and potentially in T2DM, are also transported substrates of ABCG2, and reduced ABCG2 levels may significantly alter statin absorption and cellular statin levels (see25). Here, ABCG2 is linked to type 2 diabetes mellitus.